Gainsight vs Veeva

Retention Is a Team Sport: New Value-Based Pricing for Gainsight CS + Updated Capabilities Across the Gainsight Platform

Gainsight announced new value-based pricing for Gainsight CS, with MCP access free and Staircase AI included, along with updated capabilities across the platform, announced at Pulse Europe.

Customer Success Playbook for Solo SaaS Founders

A solo-founder-focused customer success playbook recommends a lightweight, weekly-updated 5-signal health score and concrete outreach/rescue sequences that a single founder can run using a spreadsheet. The five signals are Core Feature Activation, Usage Breadth, Support Sentiment Trend, Champion Engagement, and Billing Health, each weighted and scored to classify accounts as Healthy, At Risk, or Critical. The author presents specific triggers and a multi-step churn-rescue sequence (email, short Loom, call, discount/re-onboarding). A case study reports reducing a fitness-scheduling tool's monthly churn from 8% to 3.1% and moving net revenue retention from 84% to 102% over four months. Benchmarks from ProfitWell and Baremetrics are cited to contextualize churn norms.

• The author proposes a 5-Signal Health Score for solo founders: Core Feature Activation, Usage Breadth, Support Sentiment Trend, Champion Engagement, and Billing Health, with scores aggregated 0–10.
• Actions are triggered by specific thresholds (e.g., usage drop >40% week-over-week, feature non-adoption after 30 days, support escalations >5 business days, champion change), with prescribed founder-led outreach.
• A churn-rescue sequence (Day 1 email, Day 3 Loom video, Day 7 phone call, Day 14 discount + re-onboarding) produced a 65% save rate in the author's runs (15 of 23 at-risk accounts recovered).

IQVIA Expands Veeva Partnership with Clinical Operations Applications

IQVIA and Veeva Systems announced an expansion of their partnership, with IQVIA selecting Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications for its clinical development studies. This extends the previously announced EDC partnership. The collaboration aims to increase trial speed and efficiency, strengthen site centricity, and improve decision-making for clinical research customers. All Veeva clinical solutions will also be available through IQVIA for sponsors seeking a full Veeva technology stack. Executives from both companies emphasized the benefits of integrated technologies and customer flexibility in choosing EDC, RTSM, and eCOA solutions. The announcement was made on October 13, 2026, ahead of the Veeva R&D and Quality Summit scheduled for October 20-21 in Boston.

• IQVIA selected Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications.
• Partnership expansion extends the previously announced EDC partnership.
• All Veeva clinical solutions will be available through IQVIA for sponsors.

Servier Adopts Veeva OpenData Globally for AI

Servier, a French pharmaceutical company, is standardizing its customer reference data across more than 80 countries with Veeva OpenData, part of Veeva Data Cloud. This initiative builds on Servier's use of Veeva Link Key People and aims to create an AI-ready data foundation by harmonizing fragmented data silos. The centralized data will help commercial and medical teams gain faster insights and improve efficiency. Liam Hanrahan, Director of Global Operations Excellence at Servier, highlighted that the centralized data will improve processes and enable a semantic layer for better engagement with key healthcare professionals. Veeva's president, Kilian Weiss, emphasized that 89% of AI initiatives fail due to data challenges, and Servier's data-first approach demonstrates industry leadership. The adoption replaces fragmented silos and ensures consistency for scaling advanced analytics and AI.

• Servier standardizes customer reference data with Veeva OpenData across more than 80 countries.
• The initiative builds on Servier's use of Veeva Link Key People.
• Veeva OpenData is part of Veeva Data Cloud, which also includes Veeva Link and Veeva Compass.

New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day

Veeva announces a new Study Builder Agent that can configure clinical studies in as little as one day, along with other updates including another Top 20 biopharma choosing Vault CRM and the introduction of Falcon Router for agentic triage.